Insmed Inc. buy Royal Bank of Canada
Start price
25.02.25
/
50%
€76.00
Target price
25.02.26
€95.22
Performance (%)
64.47%
End price
26.02.26
€125.00
Summary
This prediction ended on 26.02.26 with a price of €125.00. With a performance of 64.47% the BUY prediction by Royal_Bank_of_Canada was a big success. Royal_Bank_of_Canada has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 2.727% | 2.727% | 80.580% |
| iShares Core DAX® | 1.598% | 5.040% | 3.870% |
| iShares Nasdaq 100 | 3.742% | 14.947% | 36.139% |
| iShares Nikkei 225® | 3.736% | 13.892% | 43.808% |
| iShares S&P 500 | 1.816% | 8.879% | 25.510% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $100.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten